Search

Search results

373 results found

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study. Parkinsonism Relat Disord 2020;80:127-132.

Mills, KA, RB Schneider, M Saint-Hilaire, GW Ross, RA Hauser, AE Lang, MJ Halverson, et al. 2020. “Cognitive Impairment in Parkinson’s Disease: Associations Between Subjective and Objective Cognitive Decline in a Large Longitudinal Study. Parkinsonism Relat Disord 2020;80:127-132.”. Parkinsonism Relat Disord.

A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson's Disease. Sensors (Basel). 2021 Aug 12;21(16):5437. doi: 10.3390/s21165437. PMID: 34450879.

Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. J Parkinsons Dis. 2021;11(4):1663-1675. doi: 10.3233/JPD-212672. PMID: 34486986

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions. 5:100115. doi: 10.1016/j.prdoa.2021.100115. eCollection 2021. PMID: 34888518.